An advocacy group criticizes Hims & Hers Health for allegedly misleading Super Bowl ad promoting weight loss products, violating FDA regulations. Read more here.

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss ...

Telehealth company Him & Hers Health is taking a very different approach to its Super Bowl ad this year - as its new ...

DTC Telehealth Platforms - Arrangements involving telemedicine and direct-to-consumer (“DTC”) business services are expected to be a source ...

True as that might be, paying with data or ads (instead of blocking ads) is usually a win-win scenario in my eyes. This won’t be everyone’s view, but as a millennial, I remember the days when ...

The real shock was what didn’t appear on screen: a 30-second ad that plays before almost every film at AMC theaters. Since it first appeared four years ago, few things have divided moviegoers ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Once opened, compounded semaglutide typically lasts 28 days in the fridge. Compounded semaglutide, which contains the same active ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

In the UK, the first patients to receive Wegovy from the NHS, a medication containing semaglutide that is approved for weight loss, began taking the jabs last year. However, the rollout has been slow, ...

Rybelsus (semaglutide) is the first GLP-1 agonist drug that can be dosed orally, and is Novo Nordisk's third drug in the class after daily injectable Victoza (liraglutide) and weekly shot Ozempic ...